What is the management and treatment of anemia in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anemia in Pregnancy: Comprehensive Management

Definition and Diagnostic Thresholds

Anemia in pregnancy is defined as hemoglobin <11 g/dL in all trimesters, affecting 32 million pregnant women globally and contributing to over 115,000 maternal deaths annually. 1, 2

  • Use hemoglobin <11 g/dL or hematocrit <33% as diagnostic cutoffs for all trimesters, not the traditional trimester-specific values 1, 2
  • Severe anemia is defined as hemoglobin <7 g/dL, moderate as 7-9.9 g/dL, and mild as 10-10.9 g/dL 1
  • Fetal anemia is diagnosed when hemoglobin is >2 SD below the mean for gestational age, with severe fetal anemia defined as <0.55 multiples of the median 3

Screening Protocol

Screen all pregnant women at the first prenatal visit and again at 24-28 weeks gestation using hemoglobin or hematocrit testing. 1

  • Confirm positive screening with repeat testing before initiating treatment 1
  • In non-acutely ill pregnant women, make a presumptive diagnosis of iron deficiency anemia and begin treatment immediately without waiting for additional testing 1, 4
  • Screen postpartum at 4-6 weeks if risk factors present: anemia persisting through third trimester, blood loss >300 mL at delivery, or multiple birth 1, 5

Prevention Strategy

All pregnant women should receive 30 mg/day of elemental iron starting at the first prenatal visit, regardless of anemia status. 1

  • This universal supplementation prevents iron deficiency anemia development during pregnancy 1
  • Add folic acid supplementation as part of routine prenatal care to prevent neural tube defects 2, 6
  • In malaria-endemic areas, provide malaria chemoprophylaxis and anti-helminthic treatment 2

Treatment Algorithm for Maternal Anemia

Mild to Moderate Anemia (Hb 7-10.9 g/dL)

Prescribe 60-120 mg/day of elemental iron orally as first-line treatment. 1, 4

  • Provide dietary counseling on iron-rich foods (meat, poultry, fortified cereals) and factors enhancing absorption 1, 4
  • Warn patients about expected gastrointestinal side effects: dark stool, constipation, and abdominal discomfort, which are generally self-limited 1, 5
  • Vegetarian women require nearly double the supplementation (up to 240 mg daily) due to lower absorption of non-heme iron 1, 5

Monitoring Response

Reassess hemoglobin or hematocrit after 4 weeks of treatment. 1, 4

  • Expected response is an increase of ≥1 g/dL in hemoglobin or ≥3% in hematocrit 1, 5
  • If no response after 4 weeks despite compliance and absence of acute illness, perform additional testing: mean corpuscular volume, red cell distribution width, and serum ferritin 1, 5
  • Once hemoglobin normalizes for gestational age, reduce iron dose to 30 mg/day for maintenance 1

Severe Anemia or Treatment Failure

Consider intravenous iron therapy for severe anemia (Hb <7 g/dL), intolerance to oral iron, or lack of response to oral iron after 4 weeks despite compliance. 1, 7

  • Before switching to IV iron, confirm compliance with oral regimen and rule out other causes of iron-refractory anemia 1, 4
  • Ferric carboxymaltose is the preferred intravenous iron option due to rapid effectiveness and better tolerability 1, 5, 7
  • IV iron is particularly indicated in advanced pregnancy when rapid iron repletion is needed 7
  • Close surveillance during administration is recommended for all IV iron products, though anaphylactic reactions are extremely rare with non-dextran products 7

Fetal Anemia Management

Pregnancies with a fetus at significant risk for anemia should be delivered at 37-38 weeks gestation unless indications develop earlier. 3

  • Most common causes in the United States are maternal alloimmunization and parvovirus infection 3
  • Monitor middle cerebral artery peak systolic velocity by Doppler to detect fetal anemia non-invasively 3
  • Severe fetal anemia (hemoglobin <5 g/dL) can lead to hydrops fetalis and fetal death 3
  • Fetal intravascular transfusion may be needed for severe cases, particularly with parvovirus-induced aplastic crisis 3

Postpartum Management

Continue iron supplementation throughout pregnancy and the postpartum period to prevent recurrence. 1, 4

  • Screen at 4-6 weeks postpartum using hemoglobin or hematocrit in at-risk women 1, 5
  • Use hemoglobin <12 g/dL or hematocrit <36% as diagnostic thresholds for postpartum anemia 5
  • For postpartum anemia, prescribe 60-120 mg elemental iron daily orally for mild cases 5
  • Switch to IV iron for moderate-to-severe postpartum anemia (Hb <9.5 g/dL) or when rapid repletion is needed 5, 7

Critical Pitfalls to Avoid

Do not stop iron supplementation at delivery if risk factors for postpartum anemia are present. 5

  • Hemoglobin >15 g/dL or hematocrit >45% in second or third trimester warrants evaluation for poor blood volume expansion and potential pregnancy complications 1
  • Do not assume oral iron failure without confirming medication compliance and ruling out concurrent inflammatory conditions 5
  • Refer to hematology if hemoglobin <9 g/dL or hematocrit <27% for further evaluation 5
  • Consider gastroenterology consultation if occult bleeding or malabsorption is suspected 5

Relationship to Postpartum Hemorrhage

Anemia in pregnancy significantly increases the risk and impact of postpartum hemorrhage, making prevention and treatment critical for maternal safety. 2

  • Anemic women have reduced physiologic reserve to tolerate blood loss at delivery 2
  • Optimal anemia management reduces both the incidence and severity of PPH complications 2

References

Guideline

Management of Anemia in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

FIGO good practice recommendations on anemia in pregnancy, to reduce the incidence and impact of postpartum hemorrhage (PPH).

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Severe Anemia in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pharmacologic Treatment for Postpartum Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.